Book description
The new edition of this critically praised textbook continues to
provide the most comprehensive overview of the concepts, methods, and
research advances in the field; particularly the application of
molecular genomics and of neuroimaging. It has been revised and enhanced
to capitalize on the strengths of the first and second editions while
keeping it up-to-date with the field of psychiatry and epidemiology.
This comprehensive publication now includes chapters on experimental
epidemiology, gene-environment interactions, the use of case registries,
eating disorders, suicide, childhood disorders and immigrant
populations, and the epidemiology of a number of childhood disorders.
As in the first and second editions, the objective is to provide a
comprehensive, easy to understand overview of research methods for the
non-specialist. The book is ideal for students of psychiatric
epidemiology, psychiatric residents, general psychiatrists, and other
mental health professionals.
The book features a new editor, Peter Jones, from the University of
Cambridge, who joins the successful US team of Ming Tsuang and
Mauricio Tohen.
Dr. Ming Tsuang is Behavioral Genomics Endowed
Chair and University Professor, University of California and
Distinguished Professor of Psychiatry and Director, Center for
Behavioral Genomics, Department of Psychiatry, University of
California, San Diego. He also directs the Harvard Institute of
Psychiatric Epidemiology and Genetics. He was Stanley Cobb Professor
of Psychiatry and Chairman, Department of Psychiatry, Harvard Medical
School at Massachusetts Mental Health Center, where he served as
superintendent and president of Massachusetts Mental Health Institute
of Psychiatry. He received his M. D. degree from National Taiwan
University and his Ph. D. in Psychiatric Genetics and Doctor of
Science in Genetics Epidemiology from the University of London. He has
been recognized worldwide for his research in schizophrenia,
manic-depressive illness and substance abuse.
He is a member of
the Institute of Medicine, National Academy of Sciences, and served on
the National Advisory Mental Health Council, U. S. Department of
Health and Human Services. He has been elected Fellow of the American
Psychiatric Association, American College of Psychiatrists, and
British Royal Society of Psychiatrists, Fellow and former President of
the American Psychopathological Association. He is a Council Member of
the Taiwan National Health Research Institute, and Academician,
Academia Sinica of Taiwan, the highest academic institution in Taiwan.
He is currently the President of the International Society of
Psychiatric Genetics.
Dr. Tsuang is the recipient of a myriad of
awards for his work, among them: the Rema Lapouse Award for Mental
Health Epidemiology, the American Public Health Association; the
Stanley Dean Award for Research in Schizophrenia, the American College
of Psychiatrists; the National Institute of Mental Health Merit Award;
the Noyes Award for Research in Schizophrenia; the National Alliance
for Research on Schizophrenia and Depression Distinguished
Investigator Award; and the Paul H. Hoch Award, the American
Psychopathological Association. Dr. Tsuang also received the Lifetime
Achievement Award from the International Society of Psychiatric
Genetics, the Taiwanese-American Award for Achievement in Science and
Engineering, the Gold Medal Award from the Society of Biological
Psychiatry for pioneering contributions in the field of biological
psychiatry, and the Award for Research in Psychiatry, the American
Psychiatric Association.
He has authored or co-authored over 600
publications, including peer review journal papers, book chapters and
books in the areas of psychiatric epidemiology and genetics, including
major psychoses and substance abuse and spiritual health. In addition
to serving on many editorial boards of scientific journals, he is
currently the Senior Editor for Neuropsychiatric Genetics, a
section of the American Journal of Medical Genetics.
Dr. Mauricio Tohen obtained his MD degree from the National
University of Mexico. He completed a residency in Psychiatry at the
University of Toronto and a Fellowship in Psychopharmacology at McLean
Hospital, Harvard Medical School. He obtained his doctorate in
Epidemiology from the Harvard School of Public Health and an MBA from
the University of Indiana. From 1988 to 1997 he was the clinical
Director of the Bipolar and Psychotic Disorders Program at McLean
Hospital. From 1997 to 2008 he worked at Lilly Research Laboratories
in Indianapolis, Indiana where he reached the most senior scientific
rank of Distinguished Lilly Scholar. In 2009 he was appointed to the
Krus endowed chair in Psychiatry at the University of Texas Health
Science Centre at San Antonio. His research has focused on the
clinical epidemiology and psychopharmacological treatments of bipolar
disorder. Professor Tohen has over 200 original publications and over
500 book chapters and scientific abstracts. He has co-edited Mood
Disorders Across the Lifespan and Bipolar
Psychopharmacology, and has also edited Comorbidity in
Affective Disorders.
Professor Peter Jones is Head of the Department of Psychiatry
at the University of Cambridge. His particular clinical interest is in
psychotic illness and asking questions about causes and treatment. His
research concerns lifecourse influences on adult mental health and
illness, and the interface between population-based and biological
investigation and explanations.
He is a member of the Wellcome
Trust Clinical Epidemiology Research Board and the HTA Commissioning
Board.
